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.Introduction: We report the endovascular treatment of aortic arch injury due to direct puncture during
pacemaker implantation.
Report: After pacemaker implantation a 74-year-old woman showed a progressive decrease in haematocrit with
elevation of cardiac troponin-I. Coronary angiography revealed the malposition of the catheters introduced
through the aortic wall. The atrial lead was placed in the left circumﬂex coronary artery. Computed tomography
scan conﬁrmed distal aortic arch perforation. A Medtronic-Valiant stentegraft was implanted in the distal aortic
arch while the two catheters were removed. A new VVI pacemaker was implanted and, 3 days later, the patient
underwent percutaneous coronary intervention (PCI) on the dissected left circumﬂex artery. Four days later the
patient was discharged. One-year computed tomography scan showed successful repair of the injured aorta.
Discussion: Endovascular stent grafting has emerged as a less invasive therapeutic alternative to treat traumatic
or iatrogenic injuries of the distal aortic arch.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd.
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The rate of acute complications after pacemaker implanta-
tion is 4e5% and mostly related to operator experience.1
Some of these complications can be dramatic, especially
those related to venous access (haemothorax, pneumo-
thorax, venous thrombosis, etc.) or to lead malpositioning
(ventricular or atrial perforation with cardiac tamponade).
All these complications are fully described elsewhere in the
literature.1
Herein we report treatment with thoracic stentegraft
implantation (thoracic endovascular aortic repair [TEVAR])
of a rarely described dramatic complication after pacemaker
implantation: an aortic injury due to direct puncture of the
distal aortic arch with malplacement of the two pacing
leads in the left ventricle and in the left circumﬂex artery.
REPORT
A 74-year-old woman was transferred from a local hospital
and admitted to our emergency unit for an evolving haemo-
thorax and increased cardiac troponin-I and creatine kinase,
with progressive systemic hypotension and syncopal epi-
sodes. She referred fatigue and dyspnoea without chest pain.is paper was presented at the “Aortic Symposium 2012” 26e27
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implanted 48 hours before through a left subclavian access.
Blood tests showed a progressive decrease in haema-
tocrit with signiﬁcant elevation of blood level markers for
myocardial infarction, namely cardiac troponin I > 100 ng/
ml and creatine phosphokinase MB isoenzyme > 30 ng/ml.
Chest X-ray showed a large haemothorax. The transthoracic
echocardiography revealed a marked hypokinesia of the
inferolateral wall of the left ventricle, in the areas supplied
by the left circumﬂex artery (LCX), and identiﬁed mal-
placement of the two pacing leads in the left ventricle
crossing the aortic valve. A mild aortic regurgitation was
observed and the presence of the large haemothorax was
conﬁrmed. Emergent coronary angiography revealed the
malposition of the two pacemaker catheters introduced
through the aortic wall. The ventricular lead was positioned
at the apex of the left ventricle, while the atrial lead was
placed in the left circumﬂex coronary artery, as depicted in
Fig. 1B. Fortunately, the two branches of the left coronary
artery issued from the aorta by separate ostia. The
increased elevation of the markers for myocardial injury and
myocardial hypokinesia were due to LCX occlusion.
Accurate diagnosis of the direct aortic wall injuries was
established by a contrast-enhanced spiral computed to-
mography (CT) scanner. The three-dimensional volume
rendering showed perforation of the distal aortic arch wall
below the left subclavian artery (LSA) origin (Fig. 1A).
We considered it necessary and urgent to remove the
malpositioned leads, and treat the aortic injury. The trans-
thoracic echocardiography indicated the absence of
thrombus on the pacing leads. As the patient was considered
Figure 1. (A) Volume-rendered image showing perforation of the distal aortic arch; (B) coronary angiography showing leads malposition.
e18 EJVES Extra Volume 26 Issue 2 August/2013unﬁt for conventional surgery because of the evolving hae-
mothorax and myocardial ischaemia with severe ventricular
hypokinesia, we opted for endovascular treatment with
thoracic stentegraft placement. The criteria to assess
anatomical suitability for device implantation were
respected.
Stentegraft placement was performed in a hybrid oper-
ating room. The patient received general anaesthesia and
mechanical ventilation. Through left femoral artery access a
Medtronic Valiant stentegraft (Medtronic AVE, Santa Rosa,
CA, USA) was implanted in the distal aortic arch covering
the LSA origin, while the two catheters were removed from
the pocket of subclavian access. At the same time a new VVI
pacemaker was implanted through a right subclavian
access.
Subsequent aortography conﬁrmed the adequacy of the
treatment and the absence of bleeding from the aortic wall,
while the coronary angiography showed the dissection with
a subocclusion of the LCX artery.
We decided not to treat the coronary lesion at the same
time in order to reduce the risk of bleeding from the aortaFigure 2. (A) One-year computed tomography scan conﬁrming succe
percutaneous coronary intervention.following administration of antiplatelets. After TEVAR the
patient was transferred to the intensive care unit for
management of her haemodynamic instability due to the
myocardial ischaemia.
After conﬁrming absence of bleeding from the aortic
lesion, 3 days later the patient underwent percutaneous
coronary intervention with a drug-eluting stent on the
dissected LCX (Fig. 2B).
Four days after surgery the patient was transferred to a
rehabilitation center. One-month CT scan showed successful
repair of the injured aorta.
At 1-year follow-up the patient was in good condition,
showing no signs of steal phenomena due to the intentional
occlusion of the LSA. The CT scan conﬁrmed successful
repair of the injured aorta (Fig. 2A).DISCUSSION
Malposition of a pacemaker lead in the left ventricle is a
complication rarely described in the literature.2 The lead
can be introduced into the left ventricle through a patentssful repair of the injured aorta; (B) coronary angiography after
L. Di Tommaso et al. e19foramen ovale or an atrial septal defect.2 More rarely, the
lead can be inserted through the aorta for an inadvertent
puncture of the subclavian artery3 or through a direct
puncture of the aortic arch.4
In the literature we found only one case of a pacemaker
lead malpositioned in the left ventricle through direct
puncture of the aorta treated with conventional surgery
through a median sternotomy to achieve direct closure of
the aorta.
This complication usually becomes obvious through the
appearance of symptoms or at follow-up several months
later. Malpositioned leads are easily recognisable by two-
dimensional echocardiography or by chest X-ray3 revealing
the aberrant course of the ventricular lead into the aorta.
Patients with malpositioned leads in the left ventricle can
be asymptomatic or develop symptoms secondary to sys-
temic embolization. Asymptomatic patients can be treated
with a lifelong anticoagulant, such as Warfarin, to prevent
thrombo-embolic complications,5 which occur in approxi-
mately 40% of patients,5 reserving surgical extraction for
symptomatic patients or during concomitant surgery in or-
der to avoid potential mobilisation of thrombotic material
during lead manipulation.2 Surgical removal requires me-
dian sternotomy or thoracotomy, or a less invasive
approach using a right anterolateral thoracotomy.
Removal of the malpositioned lead was required in our
patient as she had developed a large haemothorax, symp-
toms indicating malplacement of one of the leads in the
LCX, and a demonstrated absence of thrombotic material.
In treating this particular aortic injury we opted for an
endovascular strategy because the patient was consideredunsuitable for conventional surgery given her current clin-
ical conditions.CONCLUSION
TEVAR has emerged as a less invasive therapeutic alterna-
tive in treating iatrogenic injuries, mostly in high-risk pa-
tients, of the distal aortic arch.CONFLICT OF INTEREST
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